Excipients
Injectable and sustained-release pharmaceutical excipients · full pharmacopoeia compliance, drop-in replacement and on-site audit supported
Featured ProductsProven track record · documents on request
Enter hub →CAS 25322-68-3
A China-based PEO supplier · direct drop-in replacement for the Dow WSR / Sumitomo series
药用辅料级（Excipact GMP）→
CAS 8001-54-5
A leading China-market supplier · quality equivalent to Novo Nordisk
辅料级 + 原料药（API）级→
CAS 6138-23-4
Injectable-grade, high-purity, low-endotoxin · benchmarked to Nagase Viita / Pfanstiehl / BioSpectra
注射级（Injectable Grade）→
聚氧乙烯PEO
A China-based PEO supplier · direct drop-in replacement for the Dow WSR / Sumitomo series
- CAS
- 25322-68-3
- Grade
- 药用辅料级（Excipact GMP）
- Pharmacopoeia
- USP-NF / EP / ChP
- Therapeutic area
- Oral sustained / controlled-release formulations
- ✓Complies with current USP-NF / EP / ChP
- ✓CoA and inter-batch consistency data provided
- ✓Direct drop-in replacement — no reformulation required
苯扎氯铵BKC
A leading China-market supplier · quality equivalent to Novo Nordisk
- CAS
- 8001-54-5
- Grade
- 辅料级 + 原料药（API）级
- Pharmacopoeia
- EP / USP / JP / ChP
- Therapeutic area
- Ophthalmic / nasal / injectable
- ✓Complies with current EP / USP / JP / ChP
- ✓CoA and inter-batch consistency data provided
- ✓Quality equivalent to Novo Nordisk
海藻糖二水合物
Injectable-grade, high-purity, low-endotoxin · benchmarked to Nagase Viita / Pfanstiehl / BioSpectra
- CAS
- 6138-23-4
- Grade
- 注射级（Injectable Grade）
- Pharmacopoeia
- USP-NF / EP / JP / ChP
- Therapeutic area
- Biologics / monoclonal antibodies
- ✓Complies with current ChP / USP-NF / EP / JP
- ✓CoA and inter-batch consistency data provided
- ✓Quality equivalent to Nagase Viita, Pfanstiehl and BioSpectra
Note: the benchmark brands and downstream product names above are for technical benchmarking and use illustration only; related trademarks belong to their respective owners. CoA is provided per batch; specifications are subject to the inspection standard confirmed in the actual order.